首页> 外文期刊>Neuropharmacology >Activation of groups I or III metabotropic glutamate receptors inhibits excitatory transmission in the rat subthalamic nucleus.
【24h】

Activation of groups I or III metabotropic glutamate receptors inhibits excitatory transmission in the rat subthalamic nucleus.

机译:I或III族代谢型谷氨酸受体的激活抑制大鼠丘脑底核中的兴奋性传递。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The subthalamic nucleus (STN) is a key nucleus in the basal ganglia motor circuit that provides the major glutamatergic excitatory input to the basal ganglia output nuclei. The STN plays an important role in the normal motor function, as well as in pathological conditions such as Parkinson's disease. Development of a complete understanding of the role of the STN in motor control will require a detailed understanding of the mechanisms involved in the regulation of excitatory and inhibitory synaptic transmission in this nucleus. Here, we report that activation of groups I or III metabotropic glutamate (mGlu) receptors, but not group II, causes a depression of excitatory transmission in the STN. In contrast, mGlu receptor activation has no effect on the inhibitory transmission in this nucleus. Further characterization of the group I mGlu receptor-induced effect on EPSCs suggests that this response is mediated by mGlu1 and not mGlu5. Further, paired pulse studies suggest that both the mGlu1 receptor and the group III mGlu receptor-mediated effects are due to a presynaptic mechanism. If these receptors are involved in endogenous synaptic transmission in the STN, these results raise the exciting possibility that selective agents targeting mGlu receptors may provide a novel approach for the treatment of motor disorders involving the STN.
机译:丘脑下核(STN)是基底神经节运动回路中的关键核,其为基底神经节输出核提供主要的谷氨酸能兴奋性输入。 STN在正常的运动功能以及帕金森氏病等病理状况中起着重要作用。要全面了解STN在运动控制中的作用,需要详细了解参与调节该核兴奋性和抑制性突触传递的机制。在这里,我们报告的激活I或III组代谢型谷氨酸(mGlu)受体,但不是II组,引起STN中兴奋性传递的降低。相反,mGlu受体激活对该核中的抑制性传递没有影响。 I组mGlu受体诱导的对EPSC的作用的进一步表征表明,该反应是由mGlu1而非mGlu5介导的。此外,成对的脉冲研究表明,mGlu1受体和第III组mGlu受体介导的作用均归因于突触前机制。如果这些受体参与STN的内源性突触传递,这些结果将增加令人兴奋的可能性,即靶向mGlu受体的选择性药物可为治疗涉及STN的运动障碍提供一种新颖的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号